Categories

Share:

New Corporate Brochure

February 17, 2020

To make your choice easier and faster 4bases’ company and product information are gathered in the new brochure

Share:

Categories

More Posts

4bases’Paper of the Month – November 2024 – Genomic ascertainment of CHEK2-related cancer predisposition

CHEK2 is a tumour-suppressing gene which encodes for the CHK2 protein, a serine/threonine kinase which plays a major role in several cell signalling pathways, such as

4bases’Paper of the Month – October 2024 – Understanding genetic variations associated with familial breast cancer

Breast cancer (BC) is the most frequent type of cancer in women, with approximately 2.2 million new cases diagnosed each year, making it the fourth

4bases’Paper of the Month – September 2024 – PIK3CA mutation analysis in circulating tumor cells of patients with hormone receptor positive metastatic breast cancer

Breast cancer is the leading cause of cancer-related deaths amongst women worldwide. One of the critical challenges in treating this disease is the presence of

4bases’Paper of the Month – August 2024 – BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients

In the 1990s, it was discovered that inherited loss-of-function pathogenic variants in the BRCA1 and BRCA2 genes (referred to as BRCA1/2 PVs) were linked to an increased familial risk of early-onset

Powered by Lifency SA © 2025